Co-Authors
This is a "connection" page, showing publications co-authored by Carlos Grijalva and Wesley Self.
Connection Strength
3.874
-
In-Hospital Pneumococcal Polysaccharide Vaccination Is Associated With Detection of Pneumococcal Vaccine Serotypes in Adults Hospitalized for Community-Acquired Pneumonia. Open Forum Infect Dis. 2015 Dec; 2(4):ofv135.
Score: 0.639
-
Respiratory Viral Detection in Children and Adults: Comparing Asymptomatic Controls and Patients With Community-Acquired Pneumonia. J Infect Dis. 2016 Feb 15; 213(4):584-91.
Score: 0.631
-
Seroprevalence of SARS-CoV-2 Among Frontline Healthcare Personnel During the First Month of Caring for Patients With COVID-19-Nashville, Tennessee. Clin Infect Dis. 2021 05 04; 72(9):1645-1648.
Score: 0.236
-
Decline in SARS-CoV-2 Antibodies After Mild Infection Among Frontline Health Care Personnel in a Multistate Hospital Network - 12 States, April-August 2020. MMWR Morb Mortal Wkly Rep. 2020 Nov 27; 69(47):1762-1766.
Score: 0.229
-
Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network - 13 Academic Medical Centers, April-June 2020. MMWR Morb Mortal Wkly Rep. 2020 Sep 04; 69(35):1221-1226.
Score: 0.225
-
Pneumococcal Community-Acquired Pneumonia Detected by Serotype-Specific Urinary Antigen Detection Assays. Clin Infect Dis. 2018 05 02; 66(10):1504-1510.
Score: 0.191
-
Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia. Clin Infect Dis. 2018 05 02; 66(10):1640-1641.
Score: 0.191
-
Effectiveness of ß-Lactam Monotherapy vs Macrolide Combination Therapy for Children Hospitalized With Pneumonia. JAMA Pediatr. 2017 12 01; 171(12):1184-1191.
Score: 0.186
-
Community-Acquired Pneumonia Visualized on CT Scans but Not Chest Radiographs: Pathogens, Severity, and Clinical Outcomes. Chest. 2018 03; 153(3):601-610.
Score: 0.182
-
Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia. Clin Infect Dis. 2017 Jul 15; 65(2):183-190.
Score: 0.181
-
Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021. MMWR Morb Mortal Wkly Rep. 2021 Aug 27; 70(34):1156-1162.
Score: 0.060
-
Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States. Clin Infect Dis. 2021 Aug 06.
Score: 0.060
-
Adults Hospitalized With Coronavirus Disease 2019 (COVID-19)-United States, March-June and October-December 2020: Implications for the Potential Effects of COVID-19 Tier-1 Vaccination on Future Hospitalizations and Outcomes. Clin Infect Dis. 2021 07 15; 73(Suppl 1):S32-S37.
Score: 0.060
-
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged =65 Years - United States, January-March 2021. MMWR Morb Mortal Wkly Rep. 2021 May 07; 70(18):674-679.
Score: 0.059
-
Thromboelastography Parameters and Platelet Count on Admission to the ICU and the Development of Venous Thromboembolism in Patients With Coronavirus Disease 2019. Crit Care Explor. 2021 Mar; 3(3):e0354.
Score: 0.058
-
Symptoms and recovery among adult outpatients with and without COVID-19 at 11 healthcare facilities-July 2020, United States. Influenza Other Respir Viruses. 2021 05; 15(3):345-351.
Score: 0.058
-
Telework Before Illness Onset Among Symptomatic Adults Aged =18 Years With and Without COVID-19 in 11 Outpatient Health Care Facilities - United States, July 2020. MMWR Morb Mortal Wkly Rep. 2020 Nov 06; 69(44):1648-1653.
Score: 0.057
-
Community and Close Contact Exposures Associated with COVID-19 Among Symptomatic Adults =18 Years in 11 Outpatient Health Care Facilities - United States, July 2020. MMWR Morb Mortal Wkly Rep. 2020 Sep 11; 69(36):1258-1264.
Score: 0.056
-
Pneumococcal epidemiology among us adults hospitalized for community-acquired pneumonia. Vaccine. 2019 05 31; 37(25):3352-3361.
Score: 0.051
-
Etiology and Impact of Coinfections in Children Hospitalized With Community-Acquired Pneumonia. J Infect Dis. 2018 06 20; 218(2):179-188.
Score: 0.048
-
In-Hospital Deaths Among Adults With Community-Acquired Pneumonia. Chest. 2018 09; 154(3):628-635.
Score: 0.048
-
Use of Multiple Imputation to Estimate the Proportion of Respiratory Virus Detections Among Patients Hospitalized With Community-Acquired Pneumonia. Open Forum Infect Dis. 2018 Apr; 5(4):ofy061.
Score: 0.047
-
Procalcitonin Accurately Identifies Hospitalized Children With Low Risk of Bacterial Community-Acquired Pneumonia. J Pediatric Infect Dis Soc. 2018 Feb 19; 7(1):46-53.
Score: 0.047
-
Long-Term Cognitive Impairment after Hospitalization for Community-Acquired Pneumonia: a Prospective Cohort Study. J Gen Intern Med. 2018 06; 33(6):929-935.
Score: 0.047
-
Rhinovirus Viremia in Patients Hospitalized With Community-Acquired Pneumonia. J Infect Dis. 2017 11 27; 216(9):1104-1111.
Score: 0.046
-
Antibiotic Prescribing for Adults Hospitalized in the Etiology of Pneumonia in the Community Study. Open Forum Infect Dis. 2017; 4(2):ofx088.
Score: 0.045
-
Relationship Between Body Mass Index and Outcomes Among Hospitalized Patients With Community-Acquired Pneumonia. J Infect Dis. 2017 06 15; 215(12):1873-1882.
Score: 0.045
-
Influence of Antibiotics on the Detection of Bacteria by Culture-Based and Culture-Independent Diagnostic Tests in Patients Hospitalized With Community-Acquired Pneumonia. Open Forum Infect Dis. 2017; 4(1):ofx014.
Score: 0.044
-
Oseltamivir Use Among Children and Adults Hospitalized With Community-Acquired Pneumonia. Open Forum Infect Dis. 2017; 4(1):ofw254.
Score: 0.044